Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 2Unknown 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 5Prostatic Neoplasms 3Urogenital Neoplasms 2Pancreatic Neoplasms 2Endometrial Neoplasms 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colorectal Neoplasms 2Brain Neoplasms 2Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8 1Wilms Tumor 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neurofibromatosis 1 1Neoplasms, Unknown Primary 1Neoplasm Metastasis 1Kidney Neoplasms 1Hot Flashes 1Head and Neck Neoplasms 1Genetic Predisposition to Disease 1Dyslexia 1Digestive System Neoplasms 1Depression 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Advanced Malignant Neoplasm 1

Interventions

Fluorouracil 128Leucovorin 120Oxaliplatin 101Irinotecan 89Bevacizumab 55Cetuximab 44Capecitabine 40Folfox protocol 29Panitumumab 22Colonoscopy 17Chemotherapy, Adjuvant 16Floxuridine 15Early Intervention, Educational 15Erlotinib Hydrochloride 13Surveys and Questionnaires 11IFL protocol 11Counseling 11Immunohistochemistry 10Gemcitabine 10Celecoxib 10Psychiatric Rehabilitation 9Methods 8Magnetic Resonance Spectroscopy 8Gene Expression Profiling 8Exercise 8Dexamethasone 8sargramostim 7Sorafenib 7Radiotherapy 7Nivolumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Colonic Neoplasms × Genetic Testing × Clear all
NCT01850654 2018-06-28

OCCPI

Ohio State University Comprehensive Cancer Center

Phase NA Completed
3,470 enrolled
GastrointestinalGynecologic

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Rectal Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡